Pure Biologics S.A. (WSE:PUR)
Poland
· Delayed Price · Currency is PLN 8.90
-0.20 (-2.20%)
May 13, 2025, 4:46 PM CET
Pure Biologics Revenue
Pure Biologics had revenue of -273.00K PLN in the quarter ending December 31, 2024, a decrease of -97.49%.
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
51
Market Cap
34.11M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 12.61B |
| Synektik Spólka Akcyjna | 556.63M |
| Voxel | 507.77M |
| Celon Pharma | 209.54M |
| Ryvu Therapeutics | 101.96M |
| Selvita | 345.76M |
| Centrum Medyczne ENEL-MED | 735.59M |
| EMC Instytut Medyczny | 809.41M |